MULTIVALENT IgM- AND IgA-Fc-BASED BINDING MOLECULES
A technology for binding molecules and polypeptides, applied in the field of multivalent binding molecules based on IgM-Fc and IgA-Fc, which can solve problems such as untested signal transduction ability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0174] Example 1: Construction of multivalent PD-L1-IgM fusion protein
[0175] Two DNA constructs encoding PD-L1-IgM fusion protein subunits were constructed by commercial suppliers. The schematic is provided as Figure 3A and Figure 3B .
[0176] The first construct included DNA encoding the signal peptide, the V1 and C2 domains of human PD-L1 (amino acids 1 to 238 of UniProtKB / Swiss-Prot: Q9NZQ7.1 presented herein as SEQ ID NO: 8), so Said DNA was fused to DNA encoding the Cμ2, Cμ3, Cμ4 and tail (tp) domains of the human IgM constant region modified with P311A and P313S amino acid substitutions in the Cμ3 domain to reduce or eliminate complement mediation. induced cytotoxicity (see P PCT Publication No. WO 2018 / 187702, which is hereby incorporated by reference in its entirety). The amino acid sequence of the precursor fusion protein encoded by the construct is presented herein as SEQ ID NO: 11, and the amino acid sequence of the mature fusion protein encoded by the con...
Embodiment 2
[0180] Example 2: Activation of PD-1 expressing T cells by PD-L1-IgM and PD-L1-H-IgM
[0181] The ability of the hexameric and pentameric forms of the PD-L1-IgM and PD-L1-H-IgM fusion proteins to activate PD-1 expressing T cells was assessed as follows. Reporter Jurkat T cells that produce light upon activation by PD-1 were obtained from DiscoverX ( PD-1 assay, catalog number 93-1104C19) was purchased and used according to the manufacturer's instructions. In these cells, the full-length PD-1 receptor is engineered with a small β-gal fragment fused to its C-terminus, and the SH2 domain of SHP-1 is engineered with a complementary β-gal fragment (EA). These constructs were stably expressed in Jurkat cells. After PD-L1 engages PD-1 on the surface of these cells, the PD-1 fusion protein is phosphorylated, resulting in the recruitment of the SHP-1 fusion protein, which generates active β-gal enzyme. This active enzyme hydrolyzes the substrate to produce chemiluminescence as a me...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



